Paper Title
Chan CK, Chang YY, Tsai YC, Chen ZW, Wu CY, Huang WC, Yen IW, Wu KH, Wu VC, Lin YH*.
J. Formos. Med. Assoc. 2021; 120(10): 1811-1820. (IF: 3.282)
Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions.
Ho Y, Chen TW, Huang TP, Chen YH*, Tarng DC*.
Antioxidants. 2021; 10(9): 1403. (IF:6.312)
Bilirubin Links HO-1 and UGT1A1*28 Gene Polymorphisms to Predict Cardiovascular Outcome in Patients Receiving Maintenance Hemodialysis.
Hung CL, Chao TF, Su CH, Liao JN, Sung KT, Yeh HI, Chiang CE*.
Heart. 2021; 107(3):208-216. (IF: 5.994)
Income level and outcomes in patients with heart failure with universal health coverage.
Hung CL, Wu YW, Lin CC, Lai CH, Juang JJM, Chao TH, Kuo L, Sung KT, Wang CY, Wang CL, Chu CY, Yu WC*, Hou CJY.
Acta Cardiol. Sin. 2021; 37(4): 337-354. (IF: 2.672)
2021 TSOC Expert Consensus on the Clinical Features, Diagnosis, and Clinical Management of Cardiac Manifestations of Fabry Disease.
Hung MH, Huang CC*, Chung CM, Chen JW.
J. Clin. Hypertens. 2021; 23(2) : 281-288. (IF: 3.738)
24-h ambulatory blood pressure variability and hypertensive nephropathy in Han Chinese hypertensive patients.
Inzucchi SE*, Docherty KF, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Solomon SD, Verma S, Belohlavek J, Bohm M, Chiang CE, de Boer RA, Diez M, Dukat A, Ljungman CEA, Bengtsson O, Langkilde AM, Sjostrand M, Jhund PS, McMurray JJV.
Diabetes Care. 2021; 44(2) :586-594. (IF: 19.112)
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF.
Jiang RH, Nishimura T, Beaser AD, Aziz ZA, Upadhyay GA, Shatz DY, Nayak HM, Liao HT, Zhan XZ, Chung FP, Xue YM, Wu SL, Tung R*.
Heart Rhythm. 2021; 18(6): 916-925. (IF: 6.343)
Spatial and transmural properties of the reentrant ventricular tachycardia circuit in arrhythmogenic right ventricular cardiomyopathy: Simultaneous epicardial and endocardial recordings.
Kao TW, Huang CC*.
J. Chin. Med. Assoc. 2021; 84(10): 911-916. (IF: 2.743)
Blood pressure management and renal protection: Revisiting hypertensive nephropathy.
Kao TW, Huang CC*.
Int. J. Mol. Sci. 2021; 22(13): 6862. (IF: 5.924)
Recent Progress in Metabolic Syndrome Research and Therapeutics.
Kawashima H, Serruys PW*, Modolo R, Pighi M, Wang RT, Ono M, Aben JP, Chang CC, Van Hauwermeiren H, Brunnett B, Cox M, Rosseel L, Mylotte D, Pibarot P, Flameng WJ, Onuma Y, Soliman O.
JACC-Cardiovasc. Interv. 2021; 14(14): 1523-1534. (IF: 11.195)
Validation of Prosthetic Mitral Regurgitation Quantification Using Novel Angiographic Platform by Mock Circulation.